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Abstract
Background: We wanted to explore to what extent environmental exposure to immune stimulants, which is
expected to be more present in rural than in urban settings, influences T cell activation and maturation in healthy
and in HIV-1-infected individuals in Burkina Faso in west Africa.
Methods: The proportion of circulating naïve T cells and the expression of the T cell activation markers, CD95 and
CD38, were analyzed by immunophenotyping and three-colour flow cytometry in 63 healthy individuals and 137
treatment-naïve HIV-1-infected subjects from Ouagadougou (urban setting) and 26 healthy adults and 61
treatment-naïve patients from Nouna (rural).
Results: A slightly higher activation level of CD4
+ and CD8
+ peripheral blood T cells was seen in healthy adults
living in Nouna than in those living in Ouagadougou. The percentages of naïve CD45RA
bright CCR7
+ T cells were
not significantly different between both study sites. Taking into consideration that relatively more HIV-1-infected
patients in Nouna were in an advanced disease stage, no relevant differences were seen in T cell activation and
maturation between patients at both study sites. As expected, the percentage of CD95
+ CD4
+ and CD38
+ CD8
+ T
cells and the respective antigen density on these cells was significantly higher in patients than in controls in both
settings. The percentage of naïve CD8
+ T cells was lower in HIV-1-infected subjects than in healthy controls
irrespective of the study site, while a lower proportion of naïve CD4
+ T cells in patients compared with controls
was seen only in Nouna.
Conclusions: Environmentally triggered immune activation may contribute to the increased expression of the
activation markers CD95 and CD38 on peripheral blood T cells from healthy adults living in rural versus urban
settings in Burkina Faso. T cell activation is further increased in HIV-1-infected individuals due to T cell loss and
high plasma viral load levels. The observed variations in T cell activation levels or the proportion of naïve T cells in
our study patients, however, are not explained by differences in CD4
+ T cell counts or HIV-1 plasma viral load
levels alone.
Background
HIV pathogenesis is characterized by a progressive
depletion of CD4
+ T cells in the course of the disease
and a chronic systemic immune activation associated
with a redistribution of T cell maturation phenotypes
[1,2]. A similar activation status has been described in
healthy individuals living in a tropical environment,
albeit less pronounced compared with HIV-infected
individuals [3-5]. Environmental stimuli, and in particu-
lar frequent intermittent infections, may be the driving
force for such activation. They may thus play an impor-
tant role in the HIV epidemic in Africa by accelerating
CD4
+ T cell depletion, resulting in faster disease pro-
gression compared with the situation in developed
countries [6-9].
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the distribution of T cell maturation phenotypes
between healthy adults in Burkina Faso [10] and pub-
lished data from populations in Europe [11]. In the few
studies that have addressed the immunological conse-
quences of HIV-1-infection in Africans, the focus has
been directed towards the expression of CD38 on CD8
+
T cells [12-14]. Upregulation of CD95 in HIV-infected
subjects has been associated with disease progression in
Europe [15-17], but has not yet been extensively studied
in African patients. To increase our understanding of
HIV-induced immune alteration in tropical settings, we
concomitantly assessed the presence of naïve T cells and
the activation level of T cells by expression of both
CD95 and CD38 in HIV-1-infected adults, as well as in
healthy controls, living in a rural or an urban setting in
Burkina Faso. We wanted to explore to what extent
environmental exposure to immune stimulants, which is
expected to be more present in rural settings, influences
T cell activation and maturation in healthy and in HIV-
1-infected individuals.
Methods
Both the National Ethics Committee in Burkina Faso
and the Institutional Ethics Committee of the University
of Heidelberg approved this study. From May 2008 to
September 2009, 137 treatment-naïve HIV-1-infected
subjects without previous exposure to single or com-
bined antiretroviral drugs or highly active antiretroviral
combination therapy (HAART) who were visiting the
outpatient clinic at the Centre Hôpitalier Universitaire
Yalgado Ouedraogo (CHUYO) in Ouagadougou, the
capital of Burkina Faso, were included (urban setting).
In Nouna, 61 treatment-naïve adult patients were
recruited at the Centre de la Recherche en Santé de
N o u n a( C R S N )f r o mJ a n u a r y2 0 0 9t oS e p t e m b e r2 0 0 9
(rural setting).
All subjects signed an informed consent form prior to
entering the study. Fresh blood samples, clinical and
socio-demographic data were collected from the patients
at regular clinical visits. For comparison of T cell
maturation and activation markers between HIV-1-
infected patients and control subjects living in urban
and rural Burkina Faso, healthy adults were recruited
from clinical and laboratory personnel at the CHUYO in
Ouagadougou (urban, n = 63) and at the CRSN in
Nouna (rural, n = 26).
At both study sites, patients and controls were always
tested simultaneously during six periods of six to eight
weeks each at approximately three-month intervals. In
order to minimize preanalytic confounders, venipunc-
ture, blood staining and fluorescence-activated cell sort-
ing (FACS) analyses were done in the same laboratory
i nt h er e s p e c t i v es t u d ys i t e s .S t o r a g et i m en e v e r
exceeded four hours. Fifty microliters of peripheral
blood anticoagulated with K3-EDTA were used to deter-
mine absolute numbers of CD4
+ and CD8
+ T cells in
the FACSCount system (BD Biosciences, San Jose, CA,
USA) according to the manufacturer’s instructions.
Plasma obtained from 125 patients in Ouagadougou and
61 patients in Nouna was used for the quantification of
viral particles with the Abbott m2000rt RealTime HIV-1
test (Abbott, Chicago, IL, USA) at the Laboratory of
Bacteriology and Virology of CHUYO after short centri-
fugation of 5ml whole blood at 3000rpm. The detection
limit was 50 HIV-1 RNA copies per ml of plasma.
Multiparametric flow cytometry was performed using
a three-colour FACSCalibur flow cytometer (FCM) in
Ouagadougou and a FACScan FCM in Nouna (both
from BD Biosciences). Measurements were done with
cocktails of fluorochrome-labelled monoclonal antibo-
dies (all from BD Biosciences) aliquoted in 3ml BD
FACS tubes and 100 μl venous whole blood anticoagu-
lated with K3-EDTA exactly as specified by the manu-
facturer. CaliBrite beads (BD Biosciences) were used to
set the instrument on a regular basis. Instrument set-
tings were controlled longitudinally and remained con-
stant during the study. Data acquisition for each analysis
was stopped manually when at least 10,000 events were
counted in the predefined gate. List mode data from all
samples were analyzed using the CellQuest Pro software,
version 5.2 (BD Biosciences).
CD4
+ and CD8
+ naïve and memory T cell subsets
were assessed with anti-CD4 or anti-CD8-PerCP, anti-
CD45RA-FITC and anti-CCR7-PE conjugated monoclo-
nal antibodies as described [10]. Naïve T cells were
identified as CD45RA
bright CCR7
+ CD4
+ or CD8
bright
lymphocytes [18-20]. T cell activation was determined
with anti-CD95-PE, anti-CD3-PerCP and anti-CD4-
FITC to assess the expression of CD95 on CD4
+ T cells,
and anti-CD38-PE, anti-CD3-PerCP and anti-CD8-FITC
to assess the expression of CD38 on CD8
+ T cells. Fig-
ure 1A to 1D shows typical examples of flow-cytometric
assessment of the percentage of naïve and activated T
cell subpopulations.
The median fluorescence intensity (MFI) of CD95 on
CD4
+ T cells is characterized by a bimodal distribution
with two peaks, i.e., CD95
dim and CD95
bright [15,21,22]
which were analyzed separately. We had shown in the
past by magnetic bead isolation and three-colour flow
cytometry [10] and by four-colour flow cytometry [21]
that the cell populations constituting the CD95
dim and
the CD95
bright peak correspond to resting naïve and
activated memory cells, respectively. CD4
+ T cells classi-
fied as “naïve”, “resting”,o r“not activated” by surface
marker analysis using, for example, CD45RA, CD45R0,
CD62L or CCR7, may thus express various levels of the
activation marker CD95. The expression of CD38 on
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+ T cells is characterized by a skewed unimodal his-
togram curve [23,24]; the cursor for MFI determination
was set on CD38
+ cells. The QuantiBrite test kit (BD
Biosciences) was used in all experiments to convert MFI
values into antibody-binding capacity (ABC) per cell
according to the instructions of the manufacturer. Since
calibration curves were generated on each instrument at
each site separately using the same batch of QuantiBrite
beads, the resulting numerical ABC values were not
influenced by the different FCM settings at the different
study sites.
Mean values and standard deviations, as well as med-
ian values and percentiles, were calculated for each vari-
able using the GraphPad Prism version 5.00 (Graph Pad
Inc., San Diego, California, USA). Differences between
healthy controls and HIV-1-infected subjects, as well as
differences between the different study sites, were ana-
lyzed using the non-parametric Mann-Whitney U-test, p
Figure 1 Flow-cytometric assessment of the percentage of naïve T cells and the expression of T cell activation markers.F o rt h e
determination of naïve T cell frequencies, whole blood was stained with anti-CD4 or -CD8 together with anti-CCR7 and anti-CD45RA antibodies.
Panels A and B show dot plots of CD4
+ and CD8
+ T cells with their respective gating of the frequencies of naïve cells as shown in the region
markers. For the determination of activated T cell frequencies, whole blood was stained with anti-CD3 and anti-CD4 or anti-CD8 together with
anti-CD95 or anti-CD38 antibodies, respectively. Panels C and D show histogram plots of CD4
+ and CD8
+ T cells expressing CD95 and CD38
activation markers, respectively. The peak of unstained control is shown in the first decade of each plot. Peaks of CD95
dim and CD95
bright on CD4
+ cell populations were separately analyzed. The expression of CD38 on CD8
+ T cells was characterized by a unique peak.
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tions between T cell activation levels and CD4
+ T cell
counts or HIV-1 plasma viral load were explored sepa-
rately in the patient cohorts from Nouna and Ouaga-
dougou by linear regression analysis using Pearson’s
correlation coefficients (r) and the coefficients of deter-
mination (R
2).
Results
Differences between healthy controls living in rural and
urban settings
Table 1 shows detailed information on the number, age
and gender distribution of HIV-1-infected patients and
healthy controls at both study sites. The number of
patients with complete multiparameter flow-cytometric
measurements varied slightly for each test because the
necessary monoclonal antibodies were not always avail-
able due to logistic delivery problems in Burkina Faso
(exact numbers are given in additional file 1). Healthy
adults living in the rural setting showed a higher percen-
tage of CD95
+ CD4
+ T cells in peripheral blood than
the controls in the urban setting (median [10
th and 90
th
percentile]: 91 [77-98] % in Nouna vs. 82 [68-95]% in
Ouagadougou, p < 0.01; see also additional file 1).
The percentage of CD38
+ CD8
+ T cells was higher in
Nouna (83 [63-98]%) than in Ouagadougou (63 [36-
83]%; p < 0.0001) and also the expression level (ABC) of
CD95 on CD95
dim CD4
+ T cells and of CD38 on CD38
+
CD8
+ T cells was significantly higher in Nouna (addi-
tional file 1). The percentages of naïve CD45RA
bright
CCR7
+ CD4
+ and CD8
+ T cells were not significantly
different between both study sites. However, there was a
moderate but significant correlation between the per-
centage of CD95
+ CD4
+ T cells and the percentage of
naïve CD4
+ T cells in healthy adults from Ouagadougou
and a tendency towards a similar correlation in the
Nouna controls (additional file 2). No such relationship
was seen between the percentage of CD38
+ CD8
+ T
cells and naïve CD8
+ T cells (data not shown).
In Ouagadougou controls, the percentage of naïve
CD8
+ T cells decreased slightly but significantly with
increasing age (additional file 3). This correlation did
not reach statistical significance in healthy adults living
in the rural setting (Nouna), probably because of the
lower number of observations in Nouna compared with
Ouagadougou (Table 1). In healthy adults from both
settings, the percentage of naïve CD4
+ T cells showed a
slight but statistically not significant trend to decrease
with increasing age (additional file 3). In healthy con-
trols, neither the percentages of activated CD95
+ or
CD38
+ T cells, nor the ABC values of CD95 or CD38,
were significantly correlated with age (data not shown).
In addition, no significant gender-related differences in
the immunologic parameters tested were seen (addi-
tional files 4 and 5).
Differences between HIV-1-infected individuals in rural
and urban settings
As shown in Table 1, patients in the rural setting of
Nouna had significantly lower CD4
+ T cell counts and
slightly higher HIV-1 plasma viral load levels compared
with patients in the city of Ouagadougou. Relatively
more patients in Nouna were in an advanced disease
stage (immunologic class C according to the 1993
Table 1 Comparison of clinical and immunological parameters between HIV-1-infected and healthy adults living in
Burkina Faso
Nouna (rural) p Ouagadougou (urban) p
Patients Controls Patients Controls
n = 61 26 - 137 63 -
Female [n = ; (%)] 44 (72%) 16 (61%) <0.0001 98 (72%)
c 25 (40%)* <0.0001
Age [years; median, range] 35 (30-43) 27 (19-35) <0.0001 35 (23-48) 28 (20-35) <0.0001
HIV-1 plasma viral load (log10 copies ml
-1] 5.8 (4.6-6.6)
[n = 61]
n.d. - 5.4 (4.0-6.2)
b
[n = 125]
n.d. -
CD4
+ T cell count [μl
-1] 174 (33-314) n.d. - 256 (118-387)
b n.d. -
CDC-stage A [n = ; (%)] 01 (02%) n.d. - 22 (16%)
c n.d. -
CDC-stage B [n = ; (%)] 23 (38%) n.d. - 55 (40%)
c n.d. -
CDC-stage C [n = ; (%)] 37 (60%) n.d. - 60 (44%)
c n.d. -
All patients were “treatment-naïve”, i.e., without known or reported previous exposure to single or combined antiretroviral drugs or highly active antiretroviral
combination therapy (HAART). If not otherwise indicated, median values are shown with 10
th and 90
th percentiles in parentheses. The Mann-Whitney U-test was
used to compare patients and controls in the rural and urban setting, as well as patients in the rural and urban setting and controls in the rural and the urban
setting separately.
Abbreviations: p - p value for the difference between patients and controls; CDC - Centers of Disease Control and Prevention immunologic staging; n.d. - not
done
ap <0.05,
bp <0.001,
cp <0.001 indicating statistically significant differences between HIV-1 infected subjects in Ouagadougou (urban) and HIV-1 infected subjects
from Nouna (rural)
*p < 0.05; **p < 0.01; ***p < 0.001, indicating statistically significant differences between healthy controls in Ouagadougou (urban) and healthy controls in Nouna
(rural)
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Consequently, the percentage of circulating naïve T cells
was lower in patients living in Nouna compared with
those living in Ouagadougou (Figure 2, additional file 1).
This difference was statistically significant only for CD4
+ T cells and was detectable also in patients with similar
CD4
+ Tc e l lc o u n t so rp a t i e n t sw i t hc o m p a r a b l eH I V - 1
plasma viral load levels (additional file 6).
When patients with CD4
+ T cell counts between 200
and 400 cells/mm
3 or patients with HIV-1 plasma viral
load levels in the range of 4 to 6 log10 RNA copies per
ml were compared, a slightly but significantly lower
anti-CD95 antibody binding capacity (ABC) of CD95
dim
CD4
+ T cells was observed in patients from Nouna
compared with patients from Ouagadogou (additional
file 7). In patients with HIV-1 plasma viral load levels in
the range of 4 to 6 log10 RNA copies per ml, the expres-
sion level (ABC) of CD38 on CD38
+ CD8
+ T cells was
slightly higher in the rural than in the urban setting. No
significant difference between patients at both study
sites was seen regarding ABC of CD95
bright CD4
+ T
cells (additional file 7).
Differences between HIV-1-infected patients and healthy
controls
Irrespective of the rural or urban setting the percentage
of CD95
+ CD4
+ and CD38
+ CD8
+ T cells was signifi-
cantly higher and the percentage of naïve CD8
+ T cells
Figure 2 Percentage of naïve and activated CD4
+ and CD8
+ T cells in patients and healthy controls. Whisker plots were used to compare
the percentages of naïve and activated CD4
+ and CD8
+ T cells between HIV-1 infected subjects and healthy controls from the different study
sites using the Mann-Whitney U-test. Panels A and B show the comparison of the percentage of naïve CD4
+ and CD8
+ T cells, respectively,
between HIV-1 infected subjects and healthy controls from Nouna (rural) and Ouagadougou (urban). Panels C and D show the comparison of
the percentage of CD95
+CD4
+ and of CD38
+CD8
+ T cells, respectively, between HIV-1 infected subjects and healthy controls from Nouna and
Ouagadougou. Symbols: (
a) indicates a statistically significant difference (p < 0.05) between HIV-1 infected subjects in Ouagadougou and HIV-1
infected subjects from Nouna; (** or ***) indicates a statistically significant difference (p < 0.001 and p < 0.0001) between healthy controls in
Ouagadougou and healthy controls in Nouna.
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u r e2 ,a d d i t i o n a lf i l e1 ) .T h ep e r c e n t a g eo fn a ï v eC D 4
+
T cells was significantly lower in HIV-1-infected sub-
jects compared to healthy controls in Nouna but not in
Ouagadougou (Figure 2, additional file 1). Anti-CD95
antibody binding capacity (ABC) of CD95
dim and
CD95
bright CD4
+ T cells as well as CD38 ABC of CD38
+
CD8
+ T cells was elevated in patients from both study
sites compared to their respective controls (Figure 3,
additional file 1).
Determinants of T cell activation in HIV-1-infected
patients
In HIV-1-infected patients living in Ouagadougou, the
percentage of CD95
+ CD4
+ T cells was negatively
correlated with CD4
+ T cell counts (r = -0.526, R
2 =
0.277, p < 0.0001) and positively correlated with HIV-1
plasma viral load levels (r = 0.434, R
2 = 0.188, p < 0.0001;
additional file 8). In the Nouna patient cohort, a similar
relationship between the percentage of CD95
+ CD4
+ T
cells and CD4
+ T cell counts was seen (r = -0.512, R
2 =
0.263, p = 0.0001) but there was no correlation between
CD95
+ CD4
+ T cells and HIV-1-plasma viral load levels
(additional file 8). The percentage of naïve CD45RA
+
CCR7
+ CD4
+ T cells showed a moderate positive correla-
tion with CD4
+ T cell counts (statistically significant only
in the Ouagadougou cohort) and no clear correlation
with HIV-1-plasma viral load levels (additional file 8).
In patients from Ouagadougou, anti-CD95 antibody
binding capacity (ABC) of CD95
bright CD4
+ T cells was
Figure 3 Expression of T cell activation markers on CD4
+ and CD8
+ T cells in patients and healthy controls. Whisker plots were used to
compare the antibody-binding capacity (ABC) of CD95
+ CD4
+ T cells (panel A and B) and CD38
+ CD8
+ T cells (panel C) between HIV-1 infected
subjects and healthy controls from the different study sites using the Mann-Whitney U-test. Panel A shows data on the ABC of CD95
dim CD4
+
CD3
+ cells, panel B on the ABC of CD95
brightCD4
+ CD3
+ cells, and panel C shows the comparison of the ABC of CD38 CD8
+ CD3
+ cells between
HIV-1 infected subjects and healthy controls from Nouna (rural) and Ouagadougou (urban). Symbols: (*) indicates statistically significant
difference (p < 0.05) between healthy controls in Ouagadougou (urban) and healthy controls in Nouna (rural).
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+ T cell
counts (Figure 4A) and positively with HIV-1 plasma
viral load levels (Figure 4B). In the Nouna patient
cohort, the negative correlation between anti-CD95
ABC of CD95
bright CD4
+ T cells and CD4
+ T cell counts
(Figure 5A) was weak and not statistically significant,
whereas the relationship with HIV-1 plasma viral load
levels was similar to the one seen in patients from Oua-
gadougou (Figure 5B). Anti-CD95 ABC of CD95
dim CD4
+ T cells was moderately negatively correlated with CD4
+ T cell counts (Figure 4C and 5C), but the level of sta-
tistical significance was reached only in patients from
Ouagadougou and not from Nouna. In patients from
both study sites, anti-CD95 ABC of CD95
dim CD4
+ T
cells showed a somewhat stronger and statistically sig-
nificant positive correlation with HIV-1 plasma viral
load levels (Figure 4D and 5D).
In the CD8
+ T cell compartment of the patients from
Ouagadougou, the percentage of CD38
+ CD8
+ T cells
was moderately negatively correlated with CD4
+ T cell
counts (r = -0.365, R
2 = 0.133, p < 0.0001) and
positively with HIV-1 plasma viral load levels (r = 0.452,
R
2 = 0.204, p < 0.0001; additional file 8). In the Nouna
patient cohort, similar relationships were seen, but did
not always reach the level of statistical significance
(additional file 8). Anti-CD38 ABC of CD38
+ CD8
+ T
cells showed a significant negative correlation with CD4
+ T cell counts in both patient cohorts (Figures 4E and
5E). The positive correlation of anti-CD38 ABC with
HIV-1 plasma viral load levels was statistically signifi-
cant in patients from Ouagadougou (Figure 4F), but not
in patients from Nouna (Figure 5F).
Discussion
Our study reveals that environmental exposure to
immune stimulants, which is expected to be more pre-
sent in rural than in urban settings, influences periph-
eral blood T cell activation in healthy individuals and in
HIV-1-infected patients in west Africa. Healthy adults in
Nouna (rural setting) showed a higher percentage of
CD95
+ CD4
+ Tc e l l sa n da ne l e v a t e de x p r e s s i o nl e v e l
(antibody-binding capacity, ABC) of CD95 on CD95
dim
Figure 4 T cell activation, CD4
+ T cell counts, and HIV-1 plasma viral load in the urban setting. Correlation between activation marker
antibody binding capacity (ABC) of peripheral blood T cells and CD4
+ T cell counts in 132 treatment-naïve HIV-1 infected patients (panels A, C
and E) as well as HIV-1 plasma viral load levels in 125 patients (panels B, D and F) living in Ouagadougou, the capital of Burkina Faso. ABC was
derived from the median fluorescence intensity as described in the Methods section. Panel A shows the correlation between the ABC of CD4
+CD95
bright T cells and CD4
+ T cell counts, panel B between the ABC of CD4
+CD95
bright T cells and HIV-1 plasma viral load. Panel C depicts the
correlation between the ABC of CD4
+CD95
dim T cells and CD4
+ T cell counts, and panel D the correlation between the ABC of CD4
+CD95
dim T
cells and HIV-1 plasma viral load. Panel E shows the correlation between the ABC of CD8
+CD38
+ T cells and CD4
+ T cell counts, and panel F
between the ABC of CD8
+CD38
+ T cells and HIV-1 plasma viral load. Correlations between variables were explored by calculation of Pearson’s
correlation coefficient (r) and the coefficient of determination (R
2), which are indicated for each analysis.
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+ T cells in peripheral blood compared with healthy
adults in Ouagadougou (urban setting). The percentage
of CD38
+ CD8
+ T cells was also higher and the expres-
sion of CD38 on CD38
+ CD8
+ T cells was increased.
Thus, healthy adults living in the rural setting harbour
more peripheral blood T cells showing signs of cellular
activation compared with individuals living in the urban
setting.
Both the expression of activation markers and the dis-
tribution pattern of T cell maturation phenotypes may
be a surrogate parameter for environmentally driven
immuno-senescence [11,26,27]. A previous study from
Ethiopia has shown comparable CD4
+ T cell counts but
higher CD8
+ T cell counts in healthy male subjects liv-
ing in Akaki (urban) and Wonji (rural). In this setting,
both the proportions of activated CD38
+ peripheral
blood T cells and of naïve CD45RA
+ CD27
+ T cells
were similar [27].
In our own study, differences in T cell activation
between the rural and the urban populations were not
accompanied by significant differences in patterns of
peripheral T cell maturation. The percentages of naïve
CD4
+ and CD8
+ T cells were not significantly higher in
healthy adults living in Ouagadougou than in those liv-
ing in Nouna. The percentage of activated CD95
+ CD4
+
T cells was negatively correlated with the percentage of
naïve CD4
+ T cells (additional file 2). No such correla-
tion was seen between naïve and activated CD8
+ Tc e l l s
(data not shown). Yet the linear decrease in the propor-
tion of naïve T cells with increasing age as described for
Europeans [11] seems to be present also in the west
African population studied by us (additional file 3).
Neither the expression of CD95
+ on CD4
+ T cells, nor
of CD38
+ on CD8
+ T cells, was significantly correlated
with age (data not shown). In contrast to published
observations from Dakar, Senegal [28], we did not see a
significant gender-related difference in T cell activation
or maturation in our study populations (additional files
4 and 5).
In our study, the observed increase in CD95
+ T cells
in healthy adults living in Nouna compared with indivi-
duals living in Ouagadougou was not caused by a reduc-
tion in the proportion of CD95
dim naïve CD4
+ T cells,
but involved changes in CD95 receptor density on the
Figure 5 T cell activation, CD4
+ T cell counts, and HIV-1 plasma viral load in the rural setting. Correlation between activation marker
antibody binding capacity (ABC) of peripheral blood T cells and CD4+ T cell counts (panels A, C and E), or HIV-1 plasma viral load levels (panels
B, D and F) in 61 treatment-naïve HIV-1 infected patients living in Nouna, rural Burkina Faso. ABC was derived from the median fluorescence
intensity as described in the Methods section. Panel A shows the correlation between the ABC of CD4
+CD95
bright T cells and CD4
+ T cell counts,
and panel B between the ABC of CD4
+CD95
bright T cells and HIV-1 plasma viral load. Panel C depicts the correlation between the ABC of CD4
+CD95
dim T cells and CD4
+ T cell counts, and panel D the correlation between the ABC of CD4
+CD95
dim T cells and HIV-1 plasma viral load.
Panel E shows the correlation between the ABC of CD8
+CD38
+ T cells and CD4
+ T cell counts, and panel F between the ABC of CD8
+CD38
+ T
cells and HIV-1 plasma viral load. Correlations between variables were explored by calculation of Pearson’s correlation coefficient (r) and the
coefficient of determination (R
2), which are indicated for each analysis.
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on CD4
+ and CD38 on CD8
+ T cells seem to be more
sensitive than the T cell maturation phenotypes towards
the mechanisms that mediate environmental influences
on the human peripheral blood T cell pool. We had
observed high prevalences of herpes viruses, dengue and
hepatitis B virus in the study area [29], and had seen
specific CD4
+ T cell responses against Plasmodium falci-
parum in 14 out of 17 healthy adults in Nouna (data not
shown). T cell responses to viral infection would be
expected to increase predominantly the expression of
CD38 on CD8
+ T cells [30]. In contrast, CD4
+ Tc e l l
responses to Plasmodium falciparum may increase the
expression of CD95 on resting naïve cells by unspecific
“bystander” activation due to an increased production of
interferon gamma [31].
One could thus hypothesize that circulating naïve T
cells in healthy adults living in the rural setting may
become constitutively CD95
+ in response to environ-
mental stimuli. It is not known whether increased CD95
expression on these cells is also increasing the sensitivity
for CD95-induced apoptosis or altering other functional
T cell properties. The CD95 signalling cascade has
pleiotropic effects on peripheral blood T cells. While
high signal intensities may silence T cell receptor-
induced activation (thus inducing T cell anergy) or may
cause activation-induced cell death via apoptosis, low
signal intensities especially in resting T cells may exert
co-stimulatory effects [32]. An increase in the expres-
sion level of CD95 on CD4
+ lymphocytes may therefore
lower the general activation threshold of resting naïve
CD4
+ T cells.
Are environmental factors acting in a similar way in
HIV-1-infected adults? There was no relevant and statis-
tically significant difference in the level of T cell activa-
tion and T cell maturation between patients from both
study sites. Relatively more patients living in the rural
setting of Nouna were in an advanced disease stage. The
small but significant difference in the percentage of
CD45RA
+ CCR7
+ naïve CD4
+ lymphocytes between
patients living in the two settings is best explained by
this fact. When patients withH I V - 1p l a s m av i r a ll o a d
levels of 4 to 6 log10 RNA copies per ml at both study
sites were compared, the expression level of CD38 on
CD8
+ T cells was slightly higher in the rural than in the
urban setting. In the CD8
+ T cell compartment, envir-
onmental influences may therefore add to HIV-induced
changes of the activation status.
Patients with comparable CD4
+ T cell counts (200 to
400 cells/mm
3) or HIV-1 plasma viral load levels (4 to 6
log10 RNA copies per ml) in the rural setting showed
lower percentages of naïve CD4
+ T cells than those in
the urban setting with similar disease activity. These
observations indicate that environmental determinants
of T cell activation may act also in the CD4
+ Tc e l l
compartment of HIV-1-infected patients living in the
rural setting.
Anti-CD95 ABC of CD95
dim CD4
+ Tc e l l sw e r e
slightly lower in the Nouna patient cohort than in
patients from Ouagadougou. It is tempting to speculate
that, due to environmental trigger mechanisms,
CD95
dim naïve CD4
+ T cells in HIV-1-infected indivi-
duals living in the rural setting are more prone to get
activated or to undergo programmed cell death (apopto-
sis) upon low level CD95 triggering than in patients
who live in an urban environment. These cells may then
either be lost due to an increased susceptibility for
CD95-induced apoptosis, which is a known feature of
peripheral blood T cells in HIV-1-infected patients [15],
or due to accelerated maturation.
We were not able to incorporate simultaneous T cell
phenotyping and assessment of T cell function into our
study protocol. However, elevated immune activation,
together with increased expression of CD95 and
increased spontaneous T cell apoptosis, has been
described in a cohort of healthy women from Nairobi,
K e n y a[ 2 6 ] ,a sw e l la si nh e a l t h ya d u l t sf r o mG h a n a
[33]. Such investigations should be included in future
studies in order to clarify the functional capacity of
CD95
dim naïve CD4
+ T cells both in HIV-1-infected
individuals and in healthy controls living under different
environmental conditions.
Infection with HIV-1, however, exerts a much stronger
effect on T cell activation than any differences in envir-
onmental conditions. Our results confirm the well-
known finding that peripheral blood T cells of HIV-1-
infected patients show a higher expression of activation
markers compared with healthy controls of similar age
[3-5]. The percentage of CD95
+ CD4
+ and CD38
+ CD8
+
T cells, anti-CD95 ABC of CD95
dim and CD95
bright CD4
+ T cells and CD38 ABC of CD38
+ CD8
+ Tc e l l sw e r e
all elevated in patients compared with controls at both
study sites. This observation was not accompanied by
similar changes in the expression of T cell maturation
markers. Only in Nouna the percentage of naïve CD4
+
T cells was significantly lower in HIV-1-infected sub-
jects than in healthy controls. A possible explanation for
this observation may be the aforementioned (hypotheti-
cal) CD95-mediated loss of CD95
dim naïve CD4
+ T cells
in HIV-1-infected individuals living in the rural setting.
The difference in age between patients and controls
does not explain the observed differences in the percen-
tage of naïve T cells.
Absolute numbers of naïve CD4
+ T cells in HIV-1-
infected subjects (mean±standard deviation: 32.5 ± 33.6
cells/mm
3 in Nouna, 72.3 ± 79.3 cells/mm
3 in Ouaga-
dougou) were significantly lower than the population-
specific reference range in our study area (5
th to 95
th
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3) [10]. In the CD8
+ T cell
compartment, the proportion of naïve lymphocytes was
significantly reduced in HIV-1-infected patients com-
pared with healthy controls at both study sites. The
absolute counts of naïve CD8
+ T cells (mean±standard
deviation: 43.0 ± 49.4 cells/mm
3 in Nouna; 53.0 ± 61.6
cells/mm
3 in Ouagadougou) were significantly lower
than those described for healthy adults in our study area
(5
th to 95
th percentile: 36 to 363 cells/mm
3) [10].
Chronic immune activation observed in HIV-1-
infected subjects has been shown to be associated both
with low CD4
+ T cell counts and high HIV-1 RNA
levels [23,34]. CD38, the most extensively studied activa-
tion marker in HIV-1-infected subjects, had been
reported to be upregulated on CD8
+ T cells in associa-
tion with disease progression [12-14,35-38]. The degree
of correlation between CD38 expression on CD8
+ T
cells and HIV-1 plasma viral load in our study was mod-
erate but comparable to other African studies [12,14].
Upregulation of the T cell activation marker CD95 on
CD4
+ had previously been reported on CD4
+ Tc e l l so f
HIV-1 infected subjects in industrialized countries and
was also associated with disease progression
[15,17,21,39]. The small but significant increase of CD95
ABC of both CD95
dim and CD95
bright CD4
+ T cells with
increasing viral load indicates that CD95 expression in
HIV-1 infected patients may be partially driven by viral
replication. Circulating CD95
+ CD4
+ T cells in patients
with advanced disease are mainly CD95
bright memory
cells, and disappearance of CD95
dim T cells in these
patients usually parallels the depletion of CD45RA
bright
CCR7
+ naïve T lymphocytes [21].
In HIV-1-infected subjectsl i v i n gi nB u r k i n aF a s o ,T
cell activation levels increased and proportions of naïve
T cells decreased both with increasing HIV-1 plasma
viral load and decreasing CD4
+ T cell counts. A signifi-
cant correlation (r = -0.456, R
2 = 0.19, p < 0.0001; data
not shown) was also observed between absolute CD4
+ T
cell counts and HIV-1 plasma viral load levels in Ouaga-
dougou. However, no causal relationship can be inferred
from our data between these parameters and changes in
T cell activation and maturation patterns in HIV-1-
infected patients. Skewed maturation and increased acti-
vation of peripheral blood T cells in HIV-1-infected
patients compared with healthy controls may be
explained by HIV-induced T cell loss. This may lead to
peripheral homeostatic expansion causing an increase in
the expression levels of CD95 or CD38 on circulating
naïve T cells as a sign of cellular cycling [40]. Differ-
ences in the exposure to other viral infections than HIV
is an unlikely cause of the deviations observed in the
CD4
+ and CD8
+ T cell compartments in these indivi-
duals. HIV replication acts as a continuous T cell
stimulus, but is expected to increase primarily the
expression of CD38 on CD8
+ T cells [35].
These observations point to a common problem in
flow cytometric analysis of T cell activation markers in
HIV-infected individuals. In the individual patient with
ah i g hC D 4
+ T cell count, an elevated expression of
CD95 on CD95
dim CD4
+ T cells and of CD38 on CD38
+
CD8
+ T cells most probably indicates a high HIV-1
plasma viral load. In the lymphopenic patient with
advanced disease and a low CD4
+ T cell count, phenoty-
pic effects of cell cycling due to homeostatic autoproli-
feration may influence the expression levels of these
molecular markers of T cell activation.
Conclusions
We conclude from our data that environmentally trig-
gered immune activation contributes to the increased
expression of the T cell activation markers, CD95 and
CD38, on peripheral blood T cells from healthy adults
living in rural versus urban settings in Burkina Faso.
Environmentally induced T cell activation is also detect-
able in HIV-1-infected individuals, albeit at a much
lower level than the changes caused by high HIV-1
plasma viral load and/or HIV-induced T cell loss. The
observed variations in T cell activation levels and the
proportion of naïve T cells in our study patients, how-
ever, are not explained by differences in CD4
+ T cell
counts and HIV-1 plasma viral load levels alone. At
least under the given environmental conditions in west
Africa, where people are continuously exposed to T cell
stimulating agents, such as viral antigens or parasite
infestations [29,41-46], the clinical value of additional
measurements of these immune markers in HIV-1-
infected patients remains to be demonstrated.
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